Cardium announced that individuals enrolled for MATRIX clinical trail have completed their evaluation period Cardium Therapeutics today announced that all sufferers enrolled in the business’s MATRIX clinical study have now completed their initial 12-week evaluation period and that it all plans to supply detailed security and efficacy data in late September 2009. The Phase 2b MATRIX clinical trial is a prospective, randomized, double-blind, placebo-controlled research of Excellarate for the potential treatment of persistent diabetic foot ulcers. The clinical research is made to evaluate security and key efficacy steps including complete wound closure, time to full wound closure, % and absolute modification in ulcer area, and wound curing trajectories at different time points, in addition to a wide range of other security and comparative healing metrics which will be used to build up a Phase 3 clinical study.Free, informational pounds reduction seminars are one method for patients to find out more about bariatric techniques without needing to make any economic commitments, also to learn whether they'd be considered a good candidate. For instance, the free informational program about gastric sleeve and the lap band in Valencia, currently happening every second and 4th Saturday afternoon of the month, helps those fighting weight problems find out more about their choices, feel safe with their potential bariatric cosmetic surgeon, and find out about the changes carrying out a surgery. Prospective patients can simply join a seminar on the Beverly Hills Doctors' website, and select a location near them.